文献速递肝病

血清肌酐变异性与肝硬化患者等待名单及肝移植后死亡率相关

Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
PubMed 文献 · Hepatology · 2022-04-15

该研究纳入2011至2018年等待肝移植的成人患者,排除有例外情况、列入时接受血液透析及临床更新少于三次者,以血清肌酐变异系数(sCr CoV)为主要暴露指标。按sCr CoV三分位分组,高变异组等待名单死亡率显著高于低变异组(34.7% vs 19.6% vs 11.7%,p<0.001),且sCr CoV与等待名单及移植后死亡率升高相关,该关联独立于基线sCr、肝病程度、急性肾损伤或慢性肾脏病。

要点

  • 女性、慢性肾脏病及晚期肝病患者更可能具有较高的血清肌酐变异系数。
  • 高变异组等待名单死亡率为34.7%,高于中变异组19.6%和低变异组11.7%(p<0.001)。
  • 血清肌酐变异系数与等待名单及肝移植后死亡率升高相关,独立于基线sCr、肝病程度、急性肾损伤或慢性肾脏病。

核心结论

  • 血清肌酐变异系数与等待名单及肝移植后死亡率升高相关,该关联独立于基线sCr、基础肝病程度、急性肾损伤或慢性肾脏病的存在。

研究设计与样本

  • 纳入2011年至2018年列入肝移植等待名单的成人患者,排除有例外情况、列入时接受血液透析及在器官共享联合网络数据库中临床更新少于三次者。
  • 以血清肌酐变异系数(sCr CoV)为主要暴露指标,按三分位分为低变异组(8.8%,IQR 6.6%-10.8%)、中变异组(17.4%,IQR 14.8%-20.4%)和高变异组(36.8%,IQR 29.5%-48.8%)。
  • 采用逻辑回归分析暴露与较高sCr CoV的关联,竞争风险回归分析暴露与等待名单死亡率的关联(以肝移植为竞争风险),Cox回归分析暴露与列入肾移植或死亡的关联。

主要发现

  • 女性、慢性肾脏病患者及晚期肝病患者更可能具有较高的sCr CoV。
  • 与低变异组相比,高变异组等待名单死亡率显著更高(34.7% vs 19.6% vs 11.7%,p<0.001)。
  • sCr CoV与等待名单及肝移植后死亡率升高相关,该关联独立于基线sCr、基础肝病程度、急性肾损伤或慢性肾脏病的存在。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Kidney function in patients with cirrhosis is dynamic. After controlling for the presence of chronic kidney disease (CKD) and acute kidney injury (AKI), we investigated the impact of variation in clinical function on pre-liver transplantation (LT) and post-LT outcomes. APPROACH AND RESULTS: We included adults listed for LT from 2011 through 2018. We excluded those with any exceptions, those on hemodialysis at listing, and those with fewer than three clinical updates in the United Network for Organ Sharing database. Our primary exposure was the serum creatinine coefficient of variation (sCr CoV). Logistic regression determined the associations between our exposures and higher sCr CoV. Competing risk regression determined the associations between our exposures and waitlist mortality, accounting for LT as a competing risk. Cox regression determined the associations between our exposures and either listing for kidney transplant or death. We divided our cohort into tertiles of sCr CoV: low variability, 8.8% (interquartile range [IQR], 6.6%-10.8%); intermediate variability, 17.4% (IQR, 14.8%-20.4%); high variability, 36.8% (IQR, 29.5%-48.8%). We demonstrate that women, those with CKD, and those with advanced liver disease were more likely to have a greater sCr CoV. Compared to those with low variability, those with high variability had significantly higher waitlist mortality (34.7% vs. 19.6% vs. 11.7%, p < 0.001). We highlight that the sCr CoV was associated with higher waitlist and post-LT mortality-an association independent of baseline sCr, the degree of underlying liver disease, the presence of AKI, or the presence of CKD. CONCLUSION: This study informs the long-term impact of the variation in kidney function we all see in clinical practice. These data highlight that all fluctuations in sCr are associated with worse pre-LT and post-LT outcomes.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Cullaro G, Hsu CY, Lai JC, et al. Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis. Hepatology. 2022. PMID: 35357707. doi:10.1002/hep.32497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。